PMID: 2114252Jan 1, 1990Paper

Numerical investigation of a novel spiral wound membrane sandwich design for an implantable bioartificial pancreas

Computers in Biology and Medicine
J G Sarver, R L Fournier

Abstract

A novel spiral wound membrane sandwich (SWMS) design for an implantable bioartificial pancreas is presented and is numerically evaluated using a comprehensive model of the glucose-insulin kinetics within the device. The spiral blood flow pattern in this design induces a convective flow of blood ultrafiltrate directly through the islet chamber. Use of ultrafiltration in addition to diffusion allows rapid transmission of blood glucose changes to the islet chamber and efficient transport of insulin from the islet chamber back to the blood stream. Simulation results suggest that the implantable bioartificial pancreas design presented in this paper may offer a means of improving the control of blood glucose levels in type I diabetics.

References

Jan 1, 1989·Diabetes·D E SutherlandD S Fryd
May 1, 1989·Archives of Otolaryngology--head & Neck Surgery·D M Sarver
Mar 1, 1987·Transplantation·D W Gray, P J Morris
Sep 1, 1988·Diabetes Care·D E Sutherland
Feb 1, 1988·Journal of Biomechanical Engineering·M Y JaffrinD Notelet
Dec 1, 1986·American Journal of Optometry and Physiological Optics·J Rosner, J Rosner
Nov 1, 1985·Artificial Organs·R C Merrell, G Basadonna
Nov 1, 1981·Diabetes·M D TrusF M Matschinsky
Dec 1, 1984·Computers and Biomedical Research, an International Journal·M NomuraH Abe
Sep 1, 1981·Acta Endocrinologica·R A DeFronzoO K Faber
May 20, 1982·The New England Journal of Medicine·D ElahiR Andres

❮ Previous
Next ❯

Citations

Jan 5, 2002·Diabetes Technology & Therapeutics·A Prokop
Jul 2, 2011·Biotechnology Journal·Shikha SharmaWei-Shou Hu
Mar 1, 2006·Journal of Biomechanical Engineering·Jean-Luc Dulong, Cécile Legallais
Mar 25, 1994·Biotechnology and Bioengineering·A G MikosR C Thomson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.